Kevin Cuevas_

Kevin H. Cuevas, MD

Founder and Medical Director

Cataract Surgeon | Cornea 
Specialist | Ophthalmologist

About Kevin H. Cuevas, MD

Born and raised in Northern California, Dr. Kevin H. Cuevas earned his medical degree from the University of Southern California School of Medicine. As a medical student at USC, Dr. Cuevas participated in research at the Doheney Eye Institute where he was involved in the emerging technology of excimer laser corneal refractive surgery. He completed his ophthalmology residency at the University of Texas Southwestern Medical Center at Dallas before attending a fellowship in Cornea and External Disease at the University of Iowa in 1997.

In 2002, Dr. Cuevas founded Rocky Mountain Ophthalmology and became a valued consultative resource for the ophthalmic community in Colorado. His interests in the cornea, external disease, and refractive surgery were complemented by his earlier research interests. Dr. Cuevas is considered by his peers as a leader in cataract and refractive surgery. He has embraced cutting-edge intraocular lens technologies and ranks among the top surgeons for implantation of presbyopia-correcting and toric intraocular lenses. Dr. Cuevas has published peer-reviewed articles and continues to lecture locally and nationally. Dr. Cuevas is board certified by The American Academy of Ophthalmology and is a member of numerous professional ophthalmology and medical societies contributing his time, expertise, perspective and support in a myriad of ways.

As a surgeon, Dr. Cuevas enjoys working with his hands. In his spare time, Dr. Cuevas uses those same skills to tie flies for his fly fishing adventures. An avid fly fisher since his early teens in California, Dr. Cuevas has fly fished worldwide in search of various freshwater and saltwater species. He is particularly passionate about fly fishing for steelhead in the Pacific Northwest, as well as chasing large roosterfish off the coast of Baja Mexico.

Dr. Cuevas Curriculum Vitae
Dr. Cuevas completed a BS undergraduate degree in both molecular biology and chemistry. He joined the formulation department at Liposome Technology, Inc. in 1986 and conducted research in various drug delivery mechanisms. Dr. Cuevas was involved in the formulation of a liposomal form of the chemotherapeutic agent doxorubicin which is currently marketed under the trade name DOXIL®.

Dr. Cuevas holds an M.D. degree from the University of Southern California. He completed his residency in ophthalmology at the University of Texas Southwestern Medical Center at Dallas with extensive training in ocular trauma. A fellowship at the University of Iowa followed in corneal and laser refractive surgery. Dr. Cuevas has conducted international research, published original literature and continues to lecture locally and nationally.

Education
 and 
Medical
 Training


1986 – San 
Diego 
State 
University, 
B.S.
1993
 – University
 of 
Southern 
California

 School 
of 
Medicine,
 M.D.
1993-1994 -
 Emmanuel 
Hospital,
 Oregon, Transitional 
Internship
1994-1997 – 
University
 of 
Texas
 Southwestern
 Medical 
Center at Dallas
Department
of 
Ophthalmology,
 Residency
1997-1998
 – University
 of
 Iowa 
Hospitals
 and
 Clinics, Department
 of
 Ophthalmology,
 Cornea
 and
 External
 Disease 
 Fellowship

Professional 
Practice 
History
 


2002‐Pres
- Rocky Mountain Ophthalmology
Golden, 
Colorado
Founder and 
Medical 
Director

1999‐2001
- Omni
 Eye 
Specialist
 P.C.
Denver, 
Colorado
Cornea 
Specialist

1998‐1999 -Eastern 
Carolina 
Eye 
Center,
 P.A.
Greenville,
 North
 Carolina
Cornea 
Specialist

Organizational 
Memberships


American
 Academy
 of
 Ophthalmology
American 
Medical 
Association
American
 Society
 of 
Cataract
 and
 Refractive
 Surgery
Castroviejo 
Cornea
 Society
Iowa Eye Association
Colorado Medical Society

Medical
 Licensure

 and 
Certifications



State
 of 
Colorado
 Board
 of 
Medical 
Examiners
State 
of 
Montana
 Board
 of 
Medical 
Examiners
National
 Board
 of 
Medical
 Examiners
American
 Board
 of
 Ophthalmology

Abstracts 
and 
Presentations


Cuevas, 
K.H.,
 Moreira, 
H., 
Fasano,
 A.P.,
 McDonnell,
 P.J.,
 Moreira,C.A.,
 Moreira,
 C.A.,
 Jr.:
 Quality
 Control 
of
 Intraocular
 Lenses
 Manufactured
 in 
Brazil.

 AAO
,
 October
 1991.
Campos,
 M., 
Cuevas,
 K.H.,
 Garbus,
 J., 
Lee,
 M.,
 McDonnell, 
P.J.:

Corneal 
Wound
 Healing
 After
 Refractive 
Keratectomy:
 
Effects
of
 the Nitrogen
 Gas 
Blower
 and
 the 
Iris
 Diaphragm.
 ARVO,
 April 
1992.
Cuevas,
 K.H., 

Campos, 
M., 

Hertzog, 
L.,
 Lee,
 M.,
 Javitt,
 J.,
McDonnell,
 P.J.: 
Efficacy 
of 
Beta-Cyclodextrin 
Encapsulated
 Prednisolone 
in 
a 
Rabbit
 Keratitis
 Model.
 ARVO, 
April 
1993.
Cuevas,
 K.H.,
 Sonkin, 
P.L.,
 Abramson,
 E.S.,
 Stidham,
 D.B.,
 Wilson,
C.A.:
 Outcome 
of 
Cataract
 Surgery 
in 
Eyes
 with
 Diabetic
 Macular
 Edema. 

ARVO, 
April
 1996.
Cuevas, 
K.H., 
Sutphin,
 J.E.: 
Acanthamoeba 
Keratitis
 Following
 Photorefractive Keratectomy. ASCRS Film Festival, October 1997.
Cuevas, 
K.H., 
Mathers, 
W.M.,
 Sutphin,
 J.E.,
 Folberg, 
R.:

 Mitomycin 
C 
for 
the 
Treatment 
of
 Primary
 Acquired
 Melanosis
 and 
Malignant 
Melanoma
 of 
the 
Conjunctiva.
 ARVO,
 May 
1997.
Publications

Campos,
 M.,
 Garbus, 
J.,
 Cuevas,
 K.H.,
 Shieh, 
E., 
McDonnell,
 P.J.: Corneal 
Wound
 Healing
 After
 Excimer Laser
 Ablation:
 
Expanding
 vs
 Contracting 
Aperatures. 

Refrac 
Corn 
Surg 
8:
 378-381,
 1992.
Campos, 
M.,
 Cuevas,
 K.H.,
 Garbus,
 J.,
 Lee,
 M., 
McDonnell,
 P.J.:
 Corneal 
Wound
 Healing 
After
 Excimer
 Laser 
Ablation:
 
Effects of
 the 
Nitrogen 
Gas 
Blower. 

Ophthalmology 
99: 
893-897,
 1992.
Li, 
Q., 
Weng, 
J.,
 Mohan, 
R.,
 Bennett,
 G.,
 Schwall,
 R.,
 Wang,
 Z., 
Tabor, 
K., 
Kim,
 J.
 Hargrave,
 S., 
Cuevas, 
K.H.,
 Wilson, 
S.:
 Hepatocyte 
Growth 
Factor
 and
 Hepatocyte
 Growth
 Factor
 Receptor 
in 
the 
Lacrimal 
Gland,
 Tears,
 and 
Cornea.

 Invest
 Opthalmol
 Vis 
Sci 
37: 
727-729, 
1996.
Salomo,
 D.R., 
Mathers, 
W.M., 
Sutphin, 
J.E.,
 Cuevas,
 K.H..,
Folberg, 
R.: 
Cytologic
 Changes
 in 
the 
Conjunctiva
Mimicking
 Malignancy
 After
 Topical 
Mitomycin 
C 
Chemotherapy.
Ophthalmology 
106:
1756-1761, 
1999.